miglustat   Click here for help

GtoPdb Ligand ID: 4841

Synonyms: N-butyl-1-deoxynojirimycin | NB-DNJ | Zavesca®
Approved drug PDB Ligand
miglustat is an approved drug (EMA (2002), FDA (2003))
Compound class: Synthetic organic
Comment: Marketed formulations may contain miglustat hydrochloride (PubChem CID 71299591).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 4
Rotatable bonds 4
Topological polar surface area 84.16
Molecular weight 219.15
XLogP -0.2
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCN1CC(O)C(C(C1CO)O)O
Isomeric SMILES CCCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
InChI InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1
InChI Key UQRORFVVSGFNRO-UTINFBMNSA-N
No information available.
Summary of Clinical Use Click here for help
Used in the treatment of Gaucher disease.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
For an overview of the mechanism of action of miglustat please see the DrugBank entry linked to from this ligand page.
External links Click here for help